YUMANITY THERAPEUTICS INC's ticker is YMTX and the CUSIP is 98872L102. A total of 26 filers reported holding YUMANITY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | -65.4% | 11,831 | -57.9% | 0.00% | – |
| Q2 2022 | $52,000 | -42.9% | 28,099 | -54.7% | 0.00% | – |
| Q1 2022 | $91,000 | -59.2% | 61,965 | -18.4% | 0.00% | -100.0% |
| Q4 2021 | $223,000 | +6.2% | 75,928 | +272.7% | 0.00% | 0.0% |
| Q3 2021 | $210,000 | -42.3% | 20,371 | -34.8% | 0.00% | 0.0% |
| Q2 2021 | $364,000 | +64.7% | 31,254 | +140.8% | 0.00% | 0.0% |
| Q4 2020 | $221,000 | – | 12,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 108,847 | $1,850,000 | 1.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 130,434 | $2,217,000 | 0.20% |
| HARBOURVEST PARTNERS LLC | 22,030 | $375,000 | 0.15% |
| Redmile Group, LLC | 611,003 | $10,387,000 | 0.13% |
| Ikarian Capital, LLC | 132,514 | $2,253,000 | 0.10% |
| Artal Group S.A. | 217,391 | $3,696,000 | 0.08% |
| Maven Securities LTD | 43,478 | $739,000 | 0.07% |
| Bain Capital Public Equity Management II, LLC | 31,331 | $533,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 14,498 | $246,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11,000 | $187,000 | 0.00% |